Poly Medicure shares rally after successfully raising Rs 1,000 cr via QIP

Poly Medicure's share price increased up to 2.22 per cent at Rs 2195 per share on the BSE in Friday's intraday deals

medical devices
SI Reporter New Delhi
2 min read Last Updated : Aug 23 2024 | 1:39 PM IST

Don't want to miss the best from Business Standard?

Poly Medicure’s share price increased up to 2.22 per cent at Rs 2,195 per share on the BSE in Friday’s intraday deals. This came after the company successfully allotted around 5.31 million equity shares to eligible qualified institutional buyers at the issue price of Rs' 1,880 per share on Thursday.

“Post the allotment the paid-up equity share capital of the company stands increased from  Rs 47.98 crore approximately consisting of 9,59,71,417 equity shares to Rs 50.64 crore consisting of  10,12,90,565 Equity Shares,” the company said in an exchange filing. 

The issue opened on August 19, 2024 and closed on August 22, 2024, successfully raising Rs 1,000 crore from the qualified institutional placement (QIP).

Poly Medicure reported a net profit of Rs 74.03 crore in the April-June quarter of financial year 2024-25 (Q1FY25), an 18.2 per cent increase year-on-year from Rs 62.69 crore for the period ending June 30, 2023, and an 8.4 per cent increase quarter-on-quarter from Rs 68.35 crore for the period ending March 31, 2024.

Total income for the period ending June 30, 2024, was Rs 401.69 crore, up 20.3 per cent year-on-year from Rs 333.94 crore for the period ending June 30, 2023, and up 2.2 per cent quarter-on-quarter from Rs 393.04 crore for the period ending March 31, 2024.

The company has a total market capitalisation of Rs 20,999.51 crore. Its shares are trading at a price to earnings multiple of 78.21 times with an earning per share of Rs 27.46, according to the data available at BSE. 

At 01:28 PM; the share price of the company was trading 1.90 per cent higher at Rs 2188.10 per share on the BSE. By comparison, the BSE Sensex was up 0.05  per cent at 81,090 levels.

Poly Medicure is a manufacturer and producer of medical devices, offering a diverse portfolio in India and internationally. 

Its product verticals include infusion therapy, oncology, anaesthesia, respiratory care, urology, gastroenterology, blood management and collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and other specialised medical devices.

 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Buzzing stocksMarkets Sensex NiftyBSE NSEPoly MedicureMarket news

First Published: Aug 23 2024 | 1:37 PM IST

Next Story